Loading...
uniQure N.V.
QURE•NASDAQ
Healthcare
Biotechnology
$13.94
$0.00(0.00%)
uniQure N.V. (QURE) Financial Performance & Statements
Review uniQure N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
71.17%
↑ 71.17%
Operating Income Growth
34.85%
↑ 34.85%
Net Income Growth
22.34%
↑ 22.34%
Operating Cash Flow Growth
-25.22%
↓ 25.22%
Operating Margin
-855.32%
↓ 855.32%
Gross Margin
40.76%
↑ 40.76%
Net Profit Margin
-1077.05%
↓ 1077.05%
ROE
-483.87%
↓ 483.87%
ROIC
-30.36%
↓ 30.36%
uniQure N.V. (QURE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for uniQure N.V. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.22M | $2.29M | $11.13M | $8.48M |
| Cost of Revenue | $619000.00 | $1.02M | $10.13M | $11.86M |
| Gross Profit | $4.60M | $1.27M | $995000.00 | -$3.37M |
| Gross Profit Ratio | $0.88 | $0.55 | $0.09 | -$0.40 |
| R&D Expenses | $38.84M | $30.59M | $35.44M | $40.53M |
| SG&A Expenses | $9.40M | $11.57M | $13.10M | $11.31M |
| Operating Expenses | $50.43M | $41.49M | $48.39M | $51.99M |
| Total Costs & Expenses | $51.05M | $42.43M | $58.52M | $63.85M |
| Interest Income | $4.24M | $4.87M | $5.80M | $6.51M |
| Interest Expense | $14.88M | $16.61M | $16.16M | $16.10M |
| Depreciation & Amortization | $4.36M | $2.99M | $2.67M | $2.63M |
| EBITDA | -$53.17M | -$24.81M | -$36.52M | -$46.24M |
| EBITDA Ratio | -$10.18 | -$10.85 | -$3.28 | -$5.45 |
| Operating Income | -$45.83M | -$40.23M | -$47.40M | -$55.36M |
| Operating Income Ratio | -$8.78 | -$17.59 | -$4.26 | -$6.52 |
| Other Income/Expenses (Net) | -$26.58M | -$4.18M | -$11.34M | -$10.73M |
| Income Before Tax | -$72.41M | -$44.41M | -$55.35M | -$64.96M |
| Income Before Tax Ratio | -$13.87 | -$19.42 | -$4.97 | -$7.66 |
| Income Tax Expense | $856000.00 | -$31000.00 | $948000.00 | $656000.00 |
| Net Income | -$73.26M | -$44.38M | -$56.30M | -$65.62M |
| Net Income Ratio | -$14.03 | -$19.40 | -$5.06 | -$7.73 |
| EPS | -$1.51 | -$0.91 | -$1.16 | -$1.36 |
| Diluted EPS | -$1.51 | -$0.91 | -$1.16 | -$1.36 |
| Weighted Avg Shares Outstanding | $48.84M | $48.72M | $48.62M | $48.38M |
| Weighted Avg Shares Outstanding (Diluted) | $48.84M | $48.72M | $48.62M | $48.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan